Access

Business

Nature 448, 121 (12 July 2007) | doi:10.1038/448121a; Published online 11 July 2007

Open Innovation Challenges

naturejobs

In brief

Abbott Laboratories, the Illinois-based drug company, reached agreement with the Brazilian government to sell its AIDS drug Kaletra there for a reduced price — lifting the threat that Brazil might license it compulsorily. On 4 July, the company said it would sell it there for $1,000 per patient per year, down by about 30%.